Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy

Charlene Wang, Mohamed Abdel-Mohsen, Matthew C. Strain, Steven M. Lada, Steven Yukl, Leslie R. Cockerham, Christopher D. Pilcher, Frederick M. Hecht, Elizabeth Sinclair, Teri Liegler, Douglas D. Richman, Steven G. Deeks, Satish K. Pillai*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Individuals who are heterozygous for the CCR5-Δ32 mutation provide a natural model to examine the effects of reduced CCR5 expression on human immunodeficiency virus (HIV) persistence. We evaluated the HIV reservoir in 18 CCR5-Δ32 heterozygotes and 54 CCR5 wild-type individuals during suppressive antiretroviral therapy. Cell-associated HIV RNA levels (P =.035), RNA to DNA transcriptional ratios (P =.013), and frequency of detectable HIV 2-long terminal repeat circular DNA (P =.013) were significantly lower in CD4+ T cells from CCR5-Δ32 heterozygotes. Cell-associated HIV RNA was significantly correlated with CCR5 surface expression on CD4+ T cells (r2 = 0.136; P =.002). Our findings suggest that curative strategies should further explore manipulation of CCR5.

Original languageEnglish (US)
Pages (from-to)1838-1843
Number of pages6
JournalJournal of Infectious Diseases
Volume210
Issue number11
DOIs
StatePublished - Dec 1 2014

Funding

Keywords

  • CCR5
  • Coreceptor
  • Eradication
  • HIV
  • HIV replication
  • HIV transcription
  • Latency
  • NF-κB
  • Reservoir
  • Δ32

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy'. Together they form a unique fingerprint.

Cite this